CEO SUMMARY: A newly introduced federal bill could signal the next chapter in the long-running debate over how laboratory developed tests (LDTs) should be regulated in the United States. Not only does the Enhancing CLIA Act seek to explicitly keep LDT authority under CLIA, it also assumes a more subtle role that the now disbanded […]
To access this post, you must purchase The Dark Report.